STOCK TITAN

[Form 4] Neuronetics, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Neuronetics, Inc. (STIM) reported an insider equity award by a director. On 10/20/2025, the director acquired 7,554 shares of common stock via a restricted stock unit (RSU) grant at $0 under the non-employee directors compensation plan, electing stock in lieu of a cash retainer.

The RSU award vested immediately upon grant, with each RSU representing one share. Following the transaction, the director’s beneficial ownership stands at 371,816 shares, held directly.

Neuronetics, Inc. (STIM) ha riferito una ricompensa azionaria interna da parte di un direttore. Il 20/10/2025, il direttore ha acquisito 7.554 azioni di azioni ordinarie tramite un grant di unità di azione vincolata (RSU) a $0 nell'ambito del piano di compensazione per i direttori non dipendenti, optando per azioni al posto di un onorario in contanti.

L'assegnazione RSU è maturata immediatamente al momento del grant, con ciascuna RSU che rappresenta una azione. Dopo la transazione, la proprietà beneficiante del direttore ammonta a 371.816 azioni, detenute direttamente.

Neuronetics, Inc. (STIM) informó una asignación interna de acciones por parte de un director. El 20/10/2025, el director adquirió 7.554 acciones de acciones comunes a través de una adjudicación de unidades de acciones restringidas (RSU) por $0 bajo el plan de compensación para directores no empleados, optando por acciones en lugar de una comisión en efectivo.

La adjudicación RSU se consolidó de inmediato al momento de la adjudicación, y cada RSU representa una acción. Tras la transacción, la propiedad beneficiosa del director asciende a 371.816 acciones, mantenidas directamente.

Neuronetics, Inc. (STIM) 는 이사에 의한 내부 주식 보상을 보고했습니다. 2025년 10월 20일, 이사는 7,554주의 보통주를 제한 주식 유닛(RSU) 부여를 통해 $0에 취득했으며, 비임원 이사 보수 계획에 따라 현금 수수료 대신 주식을 선택했습니다.

RSU 보상은 부여 즉시 가속되었으며, 각 RSU는 한 주를 나타냅니다. 거래 후 이사의 유익 소유 주식371,816주로, 직접 보유하고 있습니다.

Neuronetics, Inc. (STIM) a signalé une attribution d’actions internes par un administrateur. Le 20/10/2025, l’administrateur a acquis 7 554 actions ordinaires via une attribution d’unités d’actions restreintes (RSU) à $0 dans le cadre du plan de rémunération des administrateurs non salariés, en choisissant des actions plutôt qu’un acompte en espèces.

L’attribution RSU a été acquise immédiatement au moment de l’attribution, chaque RSU représentant une action. Suite à la transaction, la propriété bénéficiaire de l’administrateur s’élève à 371 816 actions, détenues directement.

Neuronetics, Inc. (STIM) meldete eine interne Aktienzuweisung durch einen Direktors. Am 20.10.2025 erwarb der Direktor 7.554 Aktien Stammaktien über eine zugewiesene RSU (Restricted Stock Unit) $0 gemäß dem Vergütungsplan für nicht angestellte Direktoren, wobei er Aktien statt einer Barzahlung wählte.

Die RSU-Zuweisung fiel sofort zum Zeitpunkt der Zuweisung und jede RSU stellt eine Aktie dar. Nach der Transaktion beträgt die wirtschaftlich berechtigte Eigentümerschaft des Direktors 371.816 Aktien, direkt gehalten.

Neuronetics, Inc. (STIM) أبلغت عن جائزة أسهم داخلية من قِبل مدير. في 20/10/2025، اشترى المدير 7,554 سهماً من الأسهم العادية من خلال منح وحدة أسهم مقيدة (RSU) بقيمة $0 بموجب خطة تعويضية للمديرين غير الموظفين، مُختاراً الأسهم بدلاً من راتب نقدي.

كانت جائزة RSU تنضج فوراً عند المنح، حيث تمثل كل RSU سهماً واحداً. عقب الصفقة، تبلغ الملكية المفيدة للمدير 371,816 سهماً، محفوظة مباشرة.

Positive
  • None.
Negative
  • None.

Neuronetics, Inc. (STIM) ha riferito una ricompensa azionaria interna da parte di un direttore. Il 20/10/2025, il direttore ha acquisito 7.554 azioni di azioni ordinarie tramite un grant di unità di azione vincolata (RSU) a $0 nell'ambito del piano di compensazione per i direttori non dipendenti, optando per azioni al posto di un onorario in contanti.

L'assegnazione RSU è maturata immediatamente al momento del grant, con ciascuna RSU che rappresenta una azione. Dopo la transazione, la proprietà beneficiante del direttore ammonta a 371.816 azioni, detenute direttamente.

Neuronetics, Inc. (STIM) informó una asignación interna de acciones por parte de un director. El 20/10/2025, el director adquirió 7.554 acciones de acciones comunes a través de una adjudicación de unidades de acciones restringidas (RSU) por $0 bajo el plan de compensación para directores no empleados, optando por acciones en lugar de una comisión en efectivo.

La adjudicación RSU se consolidó de inmediato al momento de la adjudicación, y cada RSU representa una acción. Tras la transacción, la propiedad beneficiosa del director asciende a 371.816 acciones, mantenidas directamente.

Neuronetics, Inc. (STIM) 는 이사에 의한 내부 주식 보상을 보고했습니다. 2025년 10월 20일, 이사는 7,554주의 보통주를 제한 주식 유닛(RSU) 부여를 통해 $0에 취득했으며, 비임원 이사 보수 계획에 따라 현금 수수료 대신 주식을 선택했습니다.

RSU 보상은 부여 즉시 가속되었으며, 각 RSU는 한 주를 나타냅니다. 거래 후 이사의 유익 소유 주식371,816주로, 직접 보유하고 있습니다.

Neuronetics, Inc. (STIM) a signalé une attribution d’actions internes par un administrateur. Le 20/10/2025, l’administrateur a acquis 7 554 actions ordinaires via une attribution d’unités d’actions restreintes (RSU) à $0 dans le cadre du plan de rémunération des administrateurs non salariés, en choisissant des actions plutôt qu’un acompte en espèces.

L’attribution RSU a été acquise immédiatement au moment de l’attribution, chaque RSU représentant une action. Suite à la transaction, la propriété bénéficiaire de l’administrateur s’élève à 371 816 actions, détenues directement.

Neuronetics, Inc. (STIM) meldete eine interne Aktienzuweisung durch einen Direktors. Am 20.10.2025 erwarb der Direktor 7.554 Aktien Stammaktien über eine zugewiesene RSU (Restricted Stock Unit) $0 gemäß dem Vergütungsplan für nicht angestellte Direktoren, wobei er Aktien statt einer Barzahlung wählte.

Die RSU-Zuweisung fiel sofort zum Zeitpunkt der Zuweisung und jede RSU stellt eine Aktie dar. Nach der Transaktion beträgt die wirtschaftlich berechtigte Eigentümerschaft des Direktors 371.816 Aktien, direkt gehalten.

Neuronetics, Inc. (STIM) أبلغت عن جائزة أسهم داخلية من قِبل مدير. في 20/10/2025، اشترى المدير 7,554 سهماً من الأسهم العادية من خلال منح وحدة أسهم مقيدة (RSU) بقيمة $0 بموجب خطة تعويضية للمديرين غير الموظفين، مُختاراً الأسهم بدلاً من راتب نقدي.

كانت جائزة RSU تنضج فوراً عند المنح، حيث تمثل كل RSU سهماً واحداً. عقب الصفقة، تبلغ الملكية المفيدة للمدير 371,816 سهماً، محفوظة مباشرة.

Neuronetics, Inc. (STIM) 报告了一项由董事授予的内部股票奖励。在 2025/10/20,董事通过受限股票单位(RSU)授予以 $0 价格购买了 7,554 股普通股,依据非雇员董事报酬计划,选择股票替代现金佣金。

RSU 奖励在授予时 立即归属,每个 RSU 代表一股股票。交易完成后,董事的 实际控制股权371,816 股,直接持有。

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MUIR GLENN P

(Last) (First) (Middle)
C/O NEURONETICS, INC.
3222 PHOENIXVILLE PIKE

(Street)
MALVERN PA 19355

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/20/2025 A(1) 7,554(2) A $0(3) 371,816 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Pursuant to the Issuer's non-employee directors compensation plan the Reporting Person elected to receive shares of the Issuer's Common Stock in lieu of a cash retainer.
2. Represents a restricted stock unit ("RSU") award that vested immediately upon the grant.
3. Each RSU represents a right to receive one share of the Issuer's common stock.
/s/ Patrick Devine, as Attorney-in-Fact 10/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Neuronetics

NASDAQ:STIM

STIM Rankings

STIM Latest News

STIM Latest SEC Filings

STIM Stock Data

195.73M
39.12M
9.44%
59.08%
8.87%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MALVERN